- Home
- MDGL vs XP Comparison
MDGL vs XP Comparison
Compare MDGL & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | XP |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 10.1B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MDGL | XP |
|---|---|---|
| Price | $442.20 | $18.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $674.45 | $22.67 |
| AVG Volume (30 Days) | 320.8K | ★ 5.9M |
| Earning Date | 04-30-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.70 | $19.15 |
| Revenue Next Year | $46.88 | $13.67 |
| P/E Ratio | ★ N/A | $11.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $265.00 | $12.20 |
| 52 Week High | $615.00 | $23.13 |
Technical Indicators
Market Signals| Indicator | MDGL | XP |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 43.07 |
| Support Level | $416.43 | $18.05 |
| Resistance Level | $446.51 | $20.37 |
| Average True Range (ATR) | 15.54 | 0.89 |
| MACD | 3.66 | -0.28 |
| Stochastic Oscillator | 67.00 | 12.84 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.